Staphylococcus aureus infection pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:
==Overview==
==Overview==
==Pathophysiology==
==Pathophysiology==
Staphylococcus aureus is a highly virulent bacteria that has been recognized as a cause of a wide variety of diseases in humans. Several strains of Staphylococcus aureus bacteria exist. The characteristic attribute of a particular strain such as toxins and extracellular factors, invasive properties (such as adherence, biofilm formation, and resistance to phagocytosis), majorly determine the pathogenesis of Staphylococcus aureus infection.<ref name="pmid26142662">{{cite journal| author=Chessa D, Ganau G, Mazzarello V| title=An overview of Staphylococcus epidermidis and Staphylococcus aureus with a focus on developing countries. | journal=J Infect Dev Ctries | year= 2015 | volume= 9 | issue= 6 | pages= 547-50 | pmid=26142662 | doi=10.3855/jidc.6923 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26142662  }} </ref> Staphylococcus aureus causes several infections ranging from mild infections to invasive diseases that are life threatening. Some of the infections caused by Staphylococcus aureus include skin and soft tissue infections, osteomyelitis, food poisoning, pneumonia, infectious endocarditis and sepsis. The following virulence factors have been recognized in the pathogenesis of Staphylococcus aureus infections:
Staphylococcus aureus is a highly virulent bacteria that has been recognized as a cause of a wide variety of diseases in humans. Several strains of Staphylococcus aureus bacteria exist. The characteristic attribute of a particular strain such as toxins and extracellular factors, invasive properties (such as adherence, biofilm formation, and resistance to phagocytosis), majorly determine the pathogenesis of Staphylococcus aureus infection.<ref name="pmid26142662">{{cite journal| author=Chessa D, Ganau G, Mazzarello V| title=An overview of Staphylococcus epidermidis and Staphylococcus aureus with a focus on developing countries. | journal=J Infect Dev Ctries | year= 2015 | volume= 9 | issue= 6 | pages= 547-50 | pmid=26142662 | doi=10.3855/jidc.6923 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26142662  }} </ref> Staphylococcus aureus causes several infections ranging from mild infections to invasive diseases that are life threatening. Some of the infections caused by Staphylococcus aureus include skin and soft tissue infections, osteomyelitis, food poisoning, pneumonia, infective endocarditis and sepsis. The following virulence factors have been recognized in the pathogenesis of Staphylococcus aureus infections:
*
*



Revision as of 17:35, 8 May 2017

Staphylococcus aureus infection Main page

Overview

Classification

Pathophysiology

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]

Overview

Pathophysiology

Staphylococcus aureus is a highly virulent bacteria that has been recognized as a cause of a wide variety of diseases in humans. Several strains of Staphylococcus aureus bacteria exist. The characteristic attribute of a particular strain such as toxins and extracellular factors, invasive properties (such as adherence, biofilm formation, and resistance to phagocytosis), majorly determine the pathogenesis of Staphylococcus aureus infection.[1] Staphylococcus aureus causes several infections ranging from mild infections to invasive diseases that are life threatening. Some of the infections caused by Staphylococcus aureus include skin and soft tissue infections, osteomyelitis, food poisoning, pneumonia, infective endocarditis and sepsis. The following virulence factors have been recognized in the pathogenesis of Staphylococcus aureus infections:

References

  1. Chessa D, Ganau G, Mazzarello V (2015). "An overview of Staphylococcus epidermidis and Staphylococcus aureus with a focus on developing countries". J Infect Dev Ctries. 9 (6): 547–50. doi:10.3855/jidc.6923. PMID 26142662.